1158 Evaluation of the potency of antibody drug conjugate-free drugs on innate immune cells by Katie Snead, Alyson J Smith, Claire Stoffers, Ryan A Heiser

1114 Targeted delivery of a potent STING agonist payload via an antibody drug conjugate drives robust antitumor activity in preclinical models by Elizabeth Gray, Priyanka Gupta, Weiping Zeng, Shyra Gardai, Kaleb Smith, Katie Snead, Adam Hill, Kellie Spahr, Alyson J Smith, Elizabeth Cummins, David Gruber, Michelle L Ulrich, Mallory Long, Katelyn Hinricher, Aditi Langalia, Patrick Burke, Peter Senter

854 SGN-B7H4V, a novel, investigational vedotin antibody-drug conjugate directed to the T cell checkpoint ligand B7-H4, shows promising activity in preclinical models by Elizabeth Gray, Shyra Gardai, Kelly Hensley, Sean Allred, Esther Trueblood, John Gosink, Katie Snead, Michelle Ulrich, Alyson Smith, Angela Epp, Disha Sahetya, Julie Hahn, Jane Haass, Sasha Lucas, Rogely Boyce, Piper Treuting, Chris Frantz, Jason Schrum, Natalya Nazarenko

SGN-B7H4V, an investigational vedotin ADC directed to the immune checkpoint ligand B7-H4, shows promising activity in preclinical models by Elizabeth Gray, Kelly Hensley, Sean Allred, Robert Thurman, Katie Snead, Michelle Ulrich, Dannah Miller, Serena Wo, Angela Epp, Disha Sahetya, Julie Hahn, Chris Frantz, Natalya Nazarenko, Kellie Spahr, Patrick Younan, Li-Ya Huang, Kristen Gahnberg, Piper M Treuting, Esther S Trueblood, John J Gosink, Evgenia Jane Haass, Mary Padilla, Alyson J Smith, Jason P Schrum, Shyra J Gardai

Get full text